27th February, 2025 In a major step towards making essential medicines more affordable, the National Pharmaceutical Pricing Authority (NPPA) has directed pharmaceutical manufacturers and marketers to reduce the Maximum Retail Price (MRP) of specific drugs that recently received customs duty…

Recent Post
- 🚨 CDSCO Issues Urgent Directive for Stopping manufacturing and marketed of Unapproved FDCs – What Pharma Manufacturers Need to Know
- 📊 Unlocking Opportunity: Comprehensive Market Research Reports Now Available at Vaayath Consulting
- 🌐Ease of Doing Business: CDSCO introduces new Updates regarding the Auto-generated Market standard Certificate (MSC) and Non-Conviction Certificate (NCC) for Licenced Medical devices.
- Complete List of Banned Drugs in India
- Government Mandates Online CRO Registration via SUGAM Portal!